Experimental drug can reduce symptoms of inflammatory bowel disease in pre-clinical models

A new study of mice and lab-grown human colon “organoids” indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical models.

Healing Lives and Healing the World at Awakening of Consciousness 2023 feat. Paul Karasik | Psychedelic Spotlight

Paul has decades of experience in the world of psychedelics. In the 1960’s he was a member of the early psychedelic communities in New York

July 6, 2023

Enhanced Semiconductor System Refurbishment: The Monmouth Scientific Modular Cleanroom at NIKON Precision’s Scottish Facility

NIKON Precision sought to enhance its semi-conductor machinery refurbishment process by incorporating an advanced cleanroom facility into its existing structure in Scotland.

May 14, 2024

New study highlights urgent need for specific biomarkers in vascular cognitive impairment and dementia diagnosis

A review in Nature Reviews Neurology discusses the pathophysiological processes in vascular cognitive impairment and dementia (VCID), emphasizing the need for specific biomarkers to differentiate

November 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.